Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy.
Marina CurraAmanda de Farias GabrielMaria Beatriz Ferreira GurianMarco Antonio Trevizani MartinsAndré Tesainer BrunettoLauro Jose GregianinManoela Domingues MartinsPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
The study contributes to the elucidation of the risk factors for OM in pediatric cancer patients. Chemotherapy protocols using MTX-HD, MTX-HD associated with doxorubicin and cyclophosphamide, and MTX-HD and cyclophosphamide a have higher incidence of severe grades of OM. Other toxicities such as hematological, hepatic, and renal also developed in patients with OM.